Benjamin Swinson1, Peadar S Waters2, Laurence Webber1, Les Nathanson1,3, David J Cavallucci1,3,4, Nicholas O'Rourke1,3,4, Richard D Bryant1,4,5. 1. Department of Surgery, Royal Brisbane and Women's Hospital, Herston, QLD, 4029, Australia. 2. Department of Surgery, Royal Brisbane and Women's Hospital, Herston, QLD, 4029, Australia. peadarwaters@hotmail.com. 3. Department of Surgery, Wesley Hospital, Auchenflower, QLD, 4066, Australia. 4. Faculty of Medicine, The University of Queensland, Brisbane, QLD, Australia. 5. St Vincent's Northside Medical Centre, St Vincent's Private Hospital Northside, 627 Rode Road, Chermside, QLD, 4032, Australia.
Abstract
BACKGROUND: Minimally invasive splenectomy is now well established for a wide range of pathologies. Portal vein thrombosis (PVT) is increasingly being recognised as a complication of splenectomy. The aim was to determine the incidence and risk factors for PVT after laparoscopic splenectomy. METHODS: All cases of elective laparoscopic splenectomy performed from 1993 to 2020 were reviewed. Parameters recorded included demographics, diagnostic criterion and post-operative outcomes. Data were analysed using Minitab V18 with a p < 0.05 considered significant. RESULTS: 210 patients (103 female, 107 male) underwent laparoscopic splenectomy (14 to 85 years). A major proportion of cases were performed for ITP (n = 77, p = 0.012) followed by lymphoma (n = 28), indeterminate lesions (n = 21) and myelofibrosis (n = 19). Ten patients developed symptomatic portal vein thrombosis (4.8%). Patients presented most commonly with pain and fever and diagnosis was confirmed by computed tomography (CT) or ultrasonography (USS). There were 10 conversions (4.8%) to open and two postoperative deaths, one from PVT and one from pneumonia. The remaining nine patients were successfully treated with anticoagulation. Of 19 patients with myelofibrosis, six patients developed PVT (p = 0.0002). Patients who developed PVT had significantly greater specimen weights (1773 g vs 348 g, p < 0.001). Forty-three patients had a specimen weight of 1 kg or greater, and of these 9 developed portal vein thrombosis (21%), versus one with PVT of 155 with a specimen weight of less than 1 kg (p < 0.0001). Myelofibrosis (p = 0.0039), specimen weight (p < 0.001) and mean platelet count (p = 0.0049) were predictive of PVT. CONCLUSION: A high index of suspicion for this complication should be maintained and prompt treatment with anticoagulation. High-risk patients should be considered for prophylactic anticoagulation and routine imaging of the portal vein.
BACKGROUND: Minimally invasive splenectomy is now well established for a wide range of pathologies. Portal vein thrombosis (PVT) is increasingly being recognised as a complication of splenectomy. The aim was to determine the incidence and risk factors for PVT after laparoscopic splenectomy. METHODS: All cases of elective laparoscopic splenectomy performed from 1993 to 2020 were reviewed. Parameters recorded included demographics, diagnostic criterion and post-operative outcomes. Data were analysed using Minitab V18 with a p < 0.05 considered significant. RESULTS: 210 patients (103 female, 107 male) underwent laparoscopic splenectomy (14 to 85 years). A major proportion of cases were performed for ITP (n = 77, p = 0.012) followed by lymphoma (n = 28), indeterminate lesions (n = 21) and myelofibrosis (n = 19). Ten patients developed symptomatic portal vein thrombosis (4.8%). Patients presented most commonly with pain and fever and diagnosis was confirmed by computed tomography (CT) or ultrasonography (USS). There were 10 conversions (4.8%) to open and two postoperative deaths, one from PVT and one from pneumonia. The remaining nine patients were successfully treated with anticoagulation. Of 19 patients with myelofibrosis, six patients developed PVT (p = 0.0002). Patients who developed PVT had significantly greater specimen weights (1773 g vs 348 g, p < 0.001). Forty-three patients had a specimen weight of 1 kg or greater, and of these 9 developed portal vein thrombosis (21%), versus one with PVT of 155 with a specimen weight of less than 1 kg (p < 0.0001). Myelofibrosis (p = 0.0039), specimen weight (p < 0.001) and mean platelet count (p = 0.0049) were predictive of PVT. CONCLUSION: A high index of suspicion for this complication should be maintained and prompt treatment with anticoagulation. High-risk patients should be considered for prophylactic anticoagulation and routine imaging of the portal vein.
Authors: N Kinjo; H Kawanaka; T Akahoshi; M Tomikawa; N Yamashita; K Konishi; K Tanoue; K Shirabe; M Hashizume; Y Maehara Journal: Br J Surg Date: 2010-06 Impact factor: 6.939
Authors: Ameet G Patel; Jane E Parker; Ben Wallwork; Keith B Kau; Nora Donaldson; Michael R Rhodes; Nicholas O'Rourke; Les Nathanson; George Fielding Journal: Ann Surg Date: 2003-08 Impact factor: 12.969
Authors: Fumihiko Fujita; Sergey Lyass; Koji Otsuka; Luca Giordano; David L Rosenbaum; Theodore M Khalili; Edward H Phillips Journal: Am Surg Date: 2003-11 Impact factor: 0.688
Authors: Siegbert Rieg; Lena Bechet; Kai Naujoks; Julia Hromek; Berit Lange; Marc-Fabian Juzek-Küpper; Katarina Stete; Matthias C Müller; Insa Jost; Winfried V Kern; Christian Theilacker Journal: Open Forum Infect Dis Date: 2020-02-13 Impact factor: 3.835